Elsevier

Resuscitation

Volume 50, Issue 3, September 2001, Pages 353-355
Resuscitation

Case report
Early postoperative thrombolytic therapy after laparotomy

https://doi.org/10.1016/S0300-9572(01)00370-7Get rights and content

Abstract

Early postoperative pulmonary embolism due to deep venous thrombosis has been reported to be associated with a mortality rate of approximately 46%. Administration of thrombolytic drugs is relatively contraindicated during this period so that conservative or surgical treatment can be considered as a therapeutical intervention. We report the case of a 68-year-old male patient who was subjected to systemic thrombolytic therapy due to pulmonary embolism on the first day after laparatomy.

Sumàrio

A embolia pulmonar post operatória precoce na sequência de trombose venosa profunda tem sido descrita como associada a uma mortalidade de 46%. O tratamento trombolı́tico é uma contra-indicação relativa pelo que, nesta fase, se considera a possibilidade tratamento conservador ou cirúrgico. Relatamos o caso de um homem de 68 anos que foi tratado com trombolı́ticos por embolia pulmonar no 1° dia post laparotomia.

Introduction

Deep venous thrombosis with subsequent cardiac and pulmonary embolism (PE) remains a serious complication after surgical procedures. The incidence varies with both the surgical procedure and preexisting risk factors and is reported to occur in 0.5–0.7% with a mortality rate of 40–60% [1], [2]. Systemic thrombolytic therapy for acute symptomatic pulmonary embolism is relatively contraindicated during the early postoperative phase due to the high risk of bleeding but decisions should be based on the relative risk versus benefit for that particular patient [3], [4]. Several investigators and clinicians have reported the use of intravenous thrombolysis for pulmonary embolism during the late postoperative phase yet (8–33 days postoperatively) [5].

Section snippets

Case report

We report a 68-year-old male patient who was admitted to the intensive care unit because of recurrent syncope 10 days after radical prostatectomy for prostatic adenocarcinoma. On admission, the patient presented with normal vital signs and no evidence of dyspnoea despite partial respiratory failure. Arterial blood gas analysis yielded a pO2 of 65 mmHg and pCO2 of 32 mmHg (6 l O2/min via face mask). He was febrile (38.6 C rectally), with a c-reactive protein of 251 mg/dl and a white blood count

Discussion

We have reported the case of a patient with a large free-floating cardiac thrombus and secondary pulmonary embolism, who underwent systemic thrombolysis on post-operative day 1 after explorative laparotomy. After twenty-five days, despite bleeding complications, the patient was transferred to an ordinary ward without any physical deficit. He left the hospital the following week. To the best of our knowledge, only Nishino et al. have reported the successful use of systemic thrombolysis after

References (7)

  • H. Zincke et al.

    Long term (15 years) results after radical prostatectomy for clinically localized prostate cancer

    J. Urol.

    (1994)
  • O. Bratt et al.

    Morbidity of pelvic lymphadenectomy, radical retropubic prostatectomy and external radiotherapy in patients with localized prostatic cancer

    Scand. J. Urol. Nephrol.

    (1994)
  • Guidelines on diagnosis and management of acute pulmonary embolism. Task Force on Pulmonary Embolism. Eur Soc Cardiol...
There are more references available in the full text version of this article.

Cited by (2)

  • Successful thrombolysis in postoperative patients with acute massive pulmonary embolism

    2013, Heart Lung and Circulation
    Citation Excerpt :

    It is conventionally thought that recent major surgery/trauma (within the past three weeks) is a contraindication to thrombolytic therapy [6]. However, some studies [7,8] have demonstrated the feasibility of full-dose thrombolysis soon after surgery. After careful consideration, we opted to treat critically ill postoperative patients with MPE, for whom surgical embolectomy and CDI were neither feasible nor available, with thrombolysis.

View full text